Orca-T Results in High GvHD-Free and Relapse-Free Survival Following Myeloablative Conditioning for Hematological Malignancies: Results of a Single Center Phase 2 and a Multicenter Phase 1b Study

Outcomes for Myelofibrosis Patients Following Myeloablative Allogeneic Stem Cell Transplantation Using the Orca-T Graft from HLA-Matched Related and Unrelated Donors

Orca-T, a Precision Treg-Engineered Donor Product, Prevents Acute GvHD With Less Immunosuppression in an Early Multicenter Experience With Myeloablative HLA-Matched Transplants